Marco Benasso
Overview
Explore the profile of Marco Benasso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
1455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nasso C, Puglisi S, Rebuzzi S, Errigo V, Rosa F, Chiola I, et al.
Immunotherapy
. 2025 Feb;
17(1):57-66.
PMID: 39893504
During the last decades, the introduction of immune checkpoint inhibitors has radically changed the treatment landscape of several cancer types, improving the prognosis and the quality of life of cancer...
2.
Roberti E, Merlano M, Ravanelli M, Alberti A, Esposito A, Gili R, et al.
Oral Oncol
. 2023 Aug;
145:106540.
PMID: 37567147
Background: Sarcopenia is frequent in head and neck squamous cell carcinoma (HNSCC), as a consequence of malnutrition related to risk factors or tumoral mass. Treatment is associated with toxicities that...
3.
Merlano M, Denaro N, Vecchio S, Licitra L, Curcio P, Benasso M, et al.
Oncology
. 2020 Jul;
98(11):763-770.
PMID: 32629446
Objectives: Induction chemotherapy followed by cetuximab and RT (IBRT) (Arm A) was compared to cisplatin/RT (CRT) (Arm B) in a randomized phase III study. Patients And Methods: Naïve patients with...
4.
Blondeaux E, Lambertini M, Michelotti A, Conte B, Benasso M, Dellepiane C, et al.
Br J Cancer
. 2020 Apr;
122(11):1611-1617.
PMID: 32231293
Background: Adjuvant chemotherapy is the standard of care in high-risk early breast cancer patients. Dose-dense should be the preferred schedule of administration. However, its long-term benefit is unknown. Methods: In...
5.
Benasso M, Bonomo P, Buglione M, Ghi M, Licitra L, Magrini S, et al.
Tumori
. 2019 Aug;
:300891619868289.
PMID: 31462160
Background: Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous disease often presenting at an already advanced stage. Cisplatin chemoradiotherapy is the standard treatment for locally advanced disease, although...
6.
Bossi P, Miceli R, Benasso M, Corvo R, Bacigalupo A, Sanguineti G, et al.
Head Neck
. 2018 Nov;
40(12):2648-2656.
PMID: 30447127
Background: We evaluated the impact of center expertise, in terms of number of patients treated, on the overall survival (OS) and progression-free survival (PFS) of patients with head and neck...
7.
Griseri G, Ceriotti M, Percivale A, Franceschi A, Santori G, Benasso M, et al.
Tumori
. 2017 Jan;
103(2):170-176.
PMID: 28058712
Introduction: Surgical resection offers the best chance of cure for patients with colorectal liver metastases (CRLMs). Two-stage hepatectomy (TSH) has been demonstrated to be safe and effective to obtain curative...
8.
Lambertini M, Ceppi M, Cognetti F, Cavazzini G, De Laurentiis M, De Placido S, et al.
Eur J Cancer
. 2016 Dec;
71:34-42.
PMID: 27951450
Background: No evidence exists to recommend a specific chemotherapy regimen in young breast cancer patients. We performed a pooled analysis of two randomised clinical trials to evaluate the efficacy of...
9.
Vanderveken O, Szturz P, Specenier P, Merlano M, Benasso M, Van Gestel D, et al.
Oncologist
. 2015 Dec;
21(1):59-71.
PMID: 26712958
Background: Platinum-based concurrent chemoradiation (CCRT) improves locoregional control and overall survival of locoregionally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) when compared to radiotherapy alone, but...
10.
Russi E, Moretto F, Rampino M, Benasso M, Bacigalupo A, De Sanctis V, et al.
Crit Rev Oncol Hematol
. 2015 Jul;
96(1):167-82.
PMID: 26187236
The adverse effects of radiation therapy, often integrated with chemotherapy and/or targeted therapies, on the skin include severe acute and chronic dermatitis associated with pain, discomfort, itching, and burning, and...